(Q24247731)

2 August 2017

0 references

1 reference

title

Antidepressants versus placebo for people with bulimia nervosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

0 references

1 reference

Josué Bacaltchuk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

Phillipa PJ Hay

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

language of work or name

English

0 references

publication date

20 October 2003

0 references

1 January 2001

1 reference

PubMed ID

11687198

Cochrane Database of Systematic Reviews

2 August 2017

2003

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

volume

2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

page(s)

CD003391

1 reference

Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Long-term outcome of bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Phenelzine vs placebo in 50 patients with bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

A double-blind trial of phenelzine in bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

The impact of prior substance abuse on treatment outcome for bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Long-term outcome of antidepressant treatment for bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Patterns of interpersonal problems associated with binge eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Medication and psychotherapy in the treatment of bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD003391

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Pharmacotherapy of the eating disorders: a commentary

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

The file drawer problem and tolerance for null results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Bulimia nervosa: an ominous variant of anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

The clinical utility of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Dimensions of response to antidepressant agents in bulimia nervosa: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Antidepressants versus placebo for the treatment of bulimia nervosa: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

Treating bulimia with desipramine. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Dissociation, childhood trauma, and the response to fluoxetine in bulimic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Long-term impact of treatment in women diagnosed with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Does interpersonal therapy help patients with binge eating disorder who fail to respond to cognitive-behavioral therapy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Pharmacotherapy of bulimia nervosa--experience with fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Bulimia treated with imipramine: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Isocarboxazid in the treatment of bulimia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Fluoxetine for bulimia nervosa following poor response to psychotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Treatment of bulimia with desipramine: a double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Bulimia: independence of antibulimic and antidepressant properties of desipramine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Ten-year follow-up of 50 patients with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

A study of the drop-outs in psychopharmacological research with bulimics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003391

7 January 2021

10.1002/14651858.CD003391

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6991155&resulttype=core&format=json

14 May 2020

1 reference